NtRON Biotechnology, Inc., a biotechnology company focused on developing innovative endolysin-based new biological drug for superbugs and unmet medical needs, today announced the strategic initiative ...

There’s no cure for genital warts, but they can be treated with a variety of methods to help manage the condition and improve ...

Study provides new insights into how the immune system responds to a highly effective viral vaccine. The findings could ...

A prior phase II trial had shown that BCG revaccination in teens led to 45.4% efficacy in reversion from positive to negative ...

The yellow fever vaccination using the live-attenuated YF17D vaccine is one of the most effective immunizations available. A ...

Oklahoma scientists find interferon-beta may help MS patients on B cell therapy fight infections like flu and Covid-19, new ...

Results further validate PlaCCine as a novel vaccine platform with potential applications in COVID-19 and other infectious diseases with epidemic implications “It is very encouraging to see strong ...

Replimune Group shares fell 28% on heavy volume with no news, despite a promising July 2025 PDUFA date for RP1 in advanced ...

WEHI scientists have uncovered a promising new way to enhance the effectiveness of vaccines by tapping into the potential of ...

Functional cure of chronic hepatitis B (CHB) remains a major clinical challenge. Current therapies—including nucleos(t)ide analogs, interferon, siRNA, and therapeutic vaccines—often fail to sustain ...